Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Schizophrenia Therapeutics”

1,468 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,468 results

Large-scale testing (Phase 3)Ended earlyNCT00366327
What this trial is testing

Study Evaluating Bifeprunox in Patients With Schizophrenia.

Who this might be right for
Schizophrenia
Wyeth is now a wholly owned subsidiary of Pfizer 400
Not applicableUnknownNCT04278027
What this trial is testing

Cognitive Remediation Therapy in Schizophrenia: Effects on Epigenetics

Who this might be right for
Schizophrenia
Hospital Clinic of Barcelona 60
Post-approval studies (Phase 4)Study completedNCT00524043
What this trial is testing

An Efficacy and Safety Study of One Dosage of Paliperidone Extended Release (ER) in Treating Patients With Schizophrenia

Who this might be right for
Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 201
Testing effectiveness (Phase 2)Study completedNCT04754750
What this trial is testing

Differences in Schizophrenia With One-month and 3-month Paliperidone Palmitate Treatment

Who this might be right for
Schizophrenics
Calo Psychiatric Center 72
Not applicableLooking for participantsNCT05851950
What this trial is testing

RUFUS - Group Rumination-focused CBT for Negative Symptoms

Who this might be right for
Psychotic Disorders
Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital 60
Not applicableStudy completedNCT00696813
What this trial is testing

Observational Study to Assess Outcomes During Antipsychotic Treatment With Paliperidone ER or Other Oral Antipsychotics

Who this might be right for
Schizophrenia
Janssen-Cilag International NV 3,064
Post-approval studies (Phase 4)Study completedNCT01157559
What this trial is testing

Efficacy and Safety With Ziprasidone in First-episode Psychosis

Who this might be right for
First Episode Psychosis
Chonbuk National University Hospital 27
Post-approval studies (Phase 4)Study completedNCT01015586
What this trial is testing

Treatment of Alcohol Dependence and Comorbid Bipolar Disorder

Who this might be right for
Alcohol DependenceBipolar DisorderDepression+2 more
Medical University of South Carolina 43
Not applicableStudy completedNCT02202694
What this trial is testing

Culturally Adapted Cognitive Behavior Therapy for Psychosis in Pakistan

Who this might be right for
Psychosis
Pakistan Institute of Living and Learning 36
Not applicableLooking for participantsNCT05890183
What this trial is testing

Improving Cognition Through Telehealth Aerobic Exercise and Cognitive Training After a First Schizophrenia Episode

Who this might be right for
SchizophreniaSchizophreniform DisorderSchizoaffective Disorder
University of California, Los Angeles 100
Not applicableStudy completedNCT01139502
What this trial is testing

Cognitive Behaviour Therapy and Cognitive Training in Work Rehabilitation for Persons With Severe Mental Illness

Who this might be right for
Mental Illness
Oslo University Hospital 140
Post-approval studies (Phase 4)Study completedNCT01157351
What this trial is testing

15 Month Study for Adults Who Have Been Diagnosed With Schizophrenia and Incarcerated

Who this might be right for
Schizophrenia
Janssen Scientific Affairs, LLC 450
Not applicableUnknownNCT04352569
What this trial is testing

Efficacy of tDCS in the Treatment of Resistant Auditory Hallucinations in Schizophrenia

Who this might be right for
SchizophreniaHallucinationsRefractory Schizophrenia
Centre hospitalier de Ville-Evrard, France 44
Very early researchUnknownNCT01411566
What this trial is testing

Clinical Intervention Psychosis and Addiction

Who this might be right for
PsychosisSubstance Abuse
University of Cologne 122
Not applicableStudy completedNCT02400502
What this trial is testing

Integrated Coping and Awareness Training

Who this might be right for
Schizophrenia
University of North Carolina, Chapel Hill 6
Large-scale testing (Phase 3)Ended earlyNCT03896945
What this trial is testing

Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Negative Symptoms of Schizophrenia

Who this might be right for
Schizophrenia
Otsuka Pharmaceutical Development & Commercialization, Inc. 136
Large-scale testing (Phase 3)Study completedNCT02013531
What this trial is testing

Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms

Who this might be right for
Major Depressive DisorderAnxiety
Otsuka Pharmaceutical Development & Commercialization, Inc. 37
Not applicableUnknownNCT03192631
What this trial is testing

Financial Incentives to Improve Acceptance of Antipsychotic Injections

Who this might be right for
SchizophreniaSchizo Affective DisorderBipolar I Disorder
Focus Community Mental Health Team 20
Post-approval studies (Phase 4)Study completedNCT00014001
What this trial is testing

CATIE- Schizophrenia Trial

Who this might be right for
Schizophrenia
National Institute of Mental Health (NIMH) 1,600
Testing effectiveness (Phase 2)Study completedNCT00482430
What this trial is testing

MK0557 for the Treatment of Cognitive Impairment in Patients With Schizophrenia (0557-027)

Who this might be right for
Paranoid SchizophreniaSchizophrenia
Merck Sharp & Dohme LLC 50
Load More Results